COST-EFFECTIVENESS OF ELDERLY HEALTH EXAMINATION PROGRAM: THE EXAMPLE OF HYPERTENSION SCREENING

被引:7
|
作者
Deng, Bing-Hwa [2 ]
Liu, Hong-Wen [3 ]
Pan, Pi-Chen [4 ,5 ]
Mau, Lih-Wen [1 ]
Chiu, Herng-Chia [1 ]
机构
[1] Kaohsiung Med Univ, Grad Inst Healthcare Adm, Kaohsiung 807, Taiwan
[2] Kaohsiung Municipal Hsiao Kang, Management Off, Kaohsiung, Taiwan
[3] Kaohsiung Med Univ Hosp, Dept Family Med, Kaohsiung, Taiwan
[4] Kaohsiung Med Univ, Yuh Ing Jr Coll Hlth Care & Management, Off Technol Cooperat, Kaohsiung, Taiwan
[5] Kaohsiung Med Univ, Fac Publ Hlth, Kaohsiung, Taiwan
来源
KAOHSIUNG JOURNAL OF MEDICAL SCIENCES | 2007年 / 23卷 / 01期
关键词
cost; effectiveness; elderly; hypertension; stroke;
D O I
10.1016/S1607-551X(09)70369-9
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The National Health Insurance (NHI) and social welfare agencies have implemented the Elderly Health Examination Program (EHEP) for years. No study has ever attempted to evaluate whether this program is cost-effective. The purposes of this study were, firstly, to understand the prevalence and incidence rates of hypertension and, secondly, to estimate the cost and effectiveness of the EHEP, focusing on hypertension screening. The data sources were: (1) hypertension and clinical information derived from the 1996 and 1997 EHEP, which was used to generate prevalence and incidence rates of hypertension; and (2) claim data of the NHI that included treatment costs of stroke patients (in- and outpatients). Hypothetical models were used to evaluate the cost-effectiveness of the hypertension screening program in various conditions. Sensitivity analysis was also employed to evaluate the effect of each estimation indicator on the cost and effectiveness of the hypertension screening program. A total of 28.3% of the elderly population in Kaohsiung (25,174 of 88,812) participated in the 1996 EHEP; 14,915 of them participated in the following 1997 EHEP, with a retention rate of 59.3%. Criteria from the Sixth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI) (systolic blood pressure/diastolic blood pressure >= 160/95 mmHg or taking antihypertensive drugs) were used; we found that prevalence and incidence rates of hypertension were 24.6% and 6.6%, respectively Hypertension rates are increasing in the aging process as shown in both prevalence and incidence models. In comparison with non-participants, the prevalence model indicates that each hypertension patient who had attended the EHEP not only saved NT$34,570-34,890 in medical and associated costs, but also increased their lifespan by 128 days. The present findings suggest that the EHEP is a cost-effective program with health and social welfare policy implications. With the relatively low participation rate of the EHEP, health and social agencies need to put more effort into the promotion of this free health examination program to attract potential participants. In doing so, the population at risk for hypertension would be identified for early treatment, and the probability of having stroke could be decreased. Consequently, health care expenditures for treatment and caregiving of stroke patients would be minimized. Finally, it should be noted that the sensitivity and values of selected parameters can modify the results of cost-effectiveness analysis. Interpretations of the effects of prevention services on costs and effectiveness need to be treated with caution.
引用
收藏
页码:17 / 24
页数:8
相关论文
共 50 条
  • [41] Costs and Cost-Effectiveness of Hypertension Screening and Treatment in Adults with Hypertension in Rural Nigeria in the Context of a Health Insurance Program (vol 11, e0157925, 2016)
    Rosendaal, N. T. A.
    Hendriks, M. E.
    Verhagen, M. D.
    Bolarinwa, O. A.
    Sanya, E. O.
    Kolo, P. M.
    [J]. PLOS ONE, 2016, 11 (09):
  • [42] Cost-effectiveness of screening for HIV
    Thrasher, AD
    Ford, CL
    Nearing, KA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (20): : 2137 - 2137
  • [43] COST-EFFECTIVENESS OF LEAD SCREENING
    BERWICK, DM
    KOMAROFF, AL
    SHERMAN, H
    [J]. CLINICAL RESEARCH, 1980, 28 (02): : A291 - A291
  • [44] The cost-effectiveness of cervical screening
    Smith, WJ
    [J]. CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 1999, 11 (01) : 83 - 85
  • [45] COST-EFFECTIVENESS OF SCREENING FOR HEMOCHROMATOSIS
    GUZMAN, G
    PHATAK, PD
    WOLL, J
    PHELPS, CE
    [J]. CLINICAL RESEARCH, 1991, 39 (02): : A348 - A348
  • [46] COST-EFFECTIVENESS ANALYSIS OF DISEASE MANAGEMENT PROGRAM OF HYPERTENSION IN SHANGHAI, CHINA
    Hu, S.
    [J]. VALUE IN HEALTH, 2010, 13 (07) : A522 - A522
  • [47] Cost-effectiveness of Chlamydial screening
    Howell, MR
    Gaydos, CA
    Quinn, TC
    [J]. SEXUALLY TRANSMITTED DISEASES, 1998, 25 (08) : 406 - 407
  • [48] Cost-effectiveness of mammography screening
    Black, WC
    Tosteson, ANA
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (02): : 111 - 111
  • [49] The cost-effectiveness of cancer screening
    De Koning, H.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 : S20 - S21
  • [50] COST-EFFECTIVENESS OF LEAD SCREENING
    BERWICK, DM
    KOMAROFF, AL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1982, 306 (23): : 1392 - 1398